Share on StockTwits

The Spectranetics (NASDAQ:SPNC) VP Donna Ford-Serbu sold 3,000 shares of The Spectranetics stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $28.26, for a total value of $84,780.00. Following the completion of the transaction, the vice president now directly owns 513 shares of the company’s stock, valued at approximately $14,497. The sale was disclosed in a filing with the SEC, which is available at this link.

SPNC has been the subject of a number of recent research reports. Analysts at Zacks upgraded shares of The Spectranetics from an “underperform” rating to a “neutral” rating in a research note on Tuesday, July 29th. They now have a $27.30 price target on the stock. Analysts at Canaccord Genuity raised their price target on shares of The Spectranetics from $27.00 to $29.00 in a research note on Monday, July 21st. They now have a “buy” rating on the stock. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. The Spectranetics has a consensus rating of “Hold” and an average price target of $27.41.

Shares of The Spectranetics (NASDAQ:SPNC) traded down 0.32% during mid-day trading on Friday, hitting $28.38. 358,222 shares of the company’s stock traded hands. The Spectranetics has a one year low of $15.52 and a one year high of $31.94. The stock has a 50-day moving average of $26.91 and a 200-day moving average of $25.59. The company’s market cap is $1.183 billion.

The Spectranetics (NASDAQ:SPNC) last posted its quarterly earnings results on Thursday, July 24th. The company reported $0.06 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.09) by $0.15. The company had revenue of $43.60 million for the quarter, compared to the consensus estimate of $42.60 million. During the same quarter last year, the company posted ($0.02) earnings per share. The Spectranetics’s revenue was up 10.5% compared to the same quarter last year. On average, analysts predict that The Spectranetics will post $-0.33 earnings per share for the current fiscal year.

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system.

Receive News & Ratings for The Spectranetics Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Spectranetics Co and related companies with Analyst Ratings Network's FREE daily email newsletter.